Completed PHASE3 INTERVENTIONAL 3-arm NCT00809471

Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) (REVIVE-D)

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in the Treatment of Erectile Dysfunction in Diabetic Men

Sponsor: VIVUS LLC

Conditions Erectile Dysfunction

Interventions avanafil placebo

Updated 8 times since 2017 Last updated: Aug 10, 2012 Started: Dec 31, 2008 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00809471, this PHASE3 trial focuses on Erectile Dysfunction and remains completed. Sponsored by VIVUS LLC, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Mar 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

VIVUS LLC

Data source: VIVUS LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Atlanta, United States , Bala-Cynwyd, United States , Beachwood, United States , Birmingham, United States , Cary, United States , Charlotte, United States , Clearwater, United States , Coral Gables, United States , El Paso, United States and 25 more locations